CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,677,859 | +60.9% | 400,159 | +85.0% | 0.02% | +64.3% |
| Q2 2023 | $2,907,596 | -65.1% | 216,339 | -57.0% | 0.01% | -65.9% |
| Q1 2023 | $8,338,546 | -11.5% | 502,928 | -0.7% | 0.04% | -21.2% |
| Q4 2022 | $9,420,826 | +2.4% | 506,496 | -29.3% | 0.05% | +4.0% |
| Q3 2022 | $9,196,000 | +1765.3% | 716,746 | +459.8% | 0.05% | +257.1% |
| Q1 2020 | $493,000 | -53.8% | 128,039 | -55.0% | 0.01% | -33.3% |
| Q4 2019 | $1,067,000 | +1047.3% | 284,598 | +1526.6% | 0.02% | +950.0% |
| Q3 2019 | $93,000 | – | 17,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |